|
 |
 |
Chapter 11
Utilization of the Mixed Lymphocyte Reaction (MLR) Assay to Determine Stem Cell
Immunogenicity and Suppression
| 11.1 |
 |
Introduction |
| 11.2 |
Experimental Design |
| 11.2.1 |
Immunogenicity Assay |
| 11.2.2 |
Suppression Assay |
| 11.2.3 |
T Cell Priming Assay |
| 11.3 |
Materials |
| 11.4 |
Methods |
| 11.4.1 |
General Considerations |
| 11.4.2 |
Safety |
| 11.4.3 |
Media Preparation |
| 11.4.4 |
Prepare Responder Cell Populations |
| 11.4.5 |
Prepare Stimulator Cell Populations |
| 11.4.6 |
Performance of Immunogenicity Assays |
| 11.4.7 |
Performance of Suppression Assays |
| 11.4.8 |
Performance of T Cell Priming Assays |
| 11.4.9 |
MLR plate culture, pulsing with 3H-thymidine, cell harvest and scintillation counting
Applicable to all three MLR assays |
| 11.5 |
Data Acquisition, Anticipated Results, Interpretation and Statistical guidelines |
| 11.5.1 |
Immunogenicity Assay |
| 11.5.2 |
Suppression Assay |
| 11.5.3 |
T Cell Priming Assay |
| 11.6 |
Discussion and Commentary |
| 11.7 |
Troubleshooting Table |
| 11.8 |
Application Notes |
| 11.9 |
Summary Points |
|
Chapter 12
A Novel Method for the Preservation of Embryonic Stem Cells Using a Quartz
Capillary Freezing System
| 12.1 |
 |
Introduction |
| 12.1.1 |
Slow Freezing Protocols |
| 12.1.2 |
Vitrification Protocols |
| 12.1.3 |
Increasing Cooling Rates for Vitrification |
| 12.1.4 |
Quartz Capillary System |
| 12.1.5 |
Apparent vitrification of CPA-laden solutions |
| 12.1.6 |
Slush Nitrogen |
| 12.1.7 |
Experimental Design |
| 12.2 |
Materials |
| 12.3 |
Methods |
| 12.3.1 |
Murine embryonic stem (ES) cell culture |
| 12.3.2 |
Preparing Slush Nitrogen |
| 12.3.3 |
Cryopreservation of Murine Embryonic Stem Cells by vitrification |
| 12.4 |
Anticipated results |
| 12.4.1 |
Cell attachment and Proliferation Post Vitrification |
| 12.4.2 |
Pluripotent properties of ES cells Post Vitrification |
| 12.5 |
Discussion and Commentary |
| 12.6 |
Troubleshooting Table |
| 12.7 |
Application Notes |
| 12.8 |
Summary Points |
Previous Chapter | Next Chapter
|